Effect of SLCO Polymorphisms on High-Dose Methotrexate Clearance in Pediatric Oncology Patients |
Vanderbilt University Medical Center / Rachael Schulte, MD |
Young Investigator Grants |
2018 |
Tennessee |
Investigation of Genetic and Molecular Mechanisms of Second Malignant Neoplasms in a Mouse Model |
University of California San Francisco / Jean Nakamura |
Young Investigator Grants |
2011 |
California |
Targeting Metabolism as a Therapeutic Approach for High-Risk MYCN-Driven Neuroblastoma |
University of Pennsylvania / Nicole Anderson, PhD |
Young Investigator Grants |
2016 |
Pennsylvania |
Mediators of Metastasis in Alveolar Rhabdomyosarcoma.
|
University of Texas Health Science Center at San Antonio / Koichi Nishijo, MD, PhD |
Young Investigator Grants |
2006 |
Texas |
Understanding the Mechanisms of HOX Gene Regulation in Normal and Leukemic Hematopoietic Stem Cells to Identify New Therapies for Pediatric AML |
Boston Children’s Hospital / Anne Robertson, PhD |
Young Investigator Grants |
2017 |
Massachusetts |
Mechanisms of CNOT3 Tumor Suppression in T-ALL and Identification of New Drugs That Specifically Kill CNOT3-Deficient T-ALL Cells |
Dana-Farber Cancer Institute / Zhaodong Li, PhD |
Young Investigator Grants |
2014 |
Massachusetts |
Elucidating Mechanisms Driving Renal Medullary Carcinomas to Deliver a Rational Approach to Cancer
Directed Therapy
|
Dana-Farber Cancer Institute / Andrew Hong, MD |
Young Investigator Grants |
2015 |
Massachusetts |
Novel Genomic Drivers in Pediatric Polyposis Syndromes |
Children’s Hospital of Philadelphia / Suzanne MacFarland, MD |
Young Investigator Grants |
2019 |
Pennsylvania |
The Regulation of Hematopoietic Stem Cell Function by Granulocyte-Colony Stimulating Factor |
Washington University / Laura Schuettpelz, MD, PhD |
Young Investigator Grants |
2013 |
Missouri |
Mechanisms of Oncogenic Transformation by TLX1/HOX11 |
University of Michigan / Mark Chiang |
Young Investigator Grants |
2011 |
Michigan |